DOI:
10.1055/s-00032260
Digestive Disease Interventions
LinksClose Window
References
Hamiditabar M, Ali M, Bolek L, Vahdati G, Tworowska I, Delpassand ES.
Safety and effectiveness of 177Lu-DOTATATE peptide receptor radionuclide therapy after regional hepatic embolization in patients with somatostatin-expressing neuroendocrine tumors.
Clin Nucl Med 2017;
42 (11) 822-828
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.